Wikipedia -WSS

Wikipedia

author：focus 2025-09-02 11:41:09 - browse：232

Stock exchange — Drew Angerer/Getty Images

Structure Therapeutics reported Monday that its oral GLP-1 drug led to weight loss in two small studies, leading shares to surge in pre-market trading.

In a 12-week Phase 2a study, the daily pill in a capsule formulation led to 6.2% placebo-adjusted weight loss. In a separate 12-week pharmacokinetics study, the company tested a new tablet formulation of the drug, called GSBR-1290, and it led to placebo-adjusted weight loss of up to 6.9%.

Though it’s difficult to compare across different studies, the results appear to approach the levels of weight loss seen at 12 weeks in a separate Phase 2 study of Eli Lilly’s GLP-1 pill called orforglipron. That entire study lasted 36 weeks, but at 12 weeks, participants had about 6%-7% placebo-adjusted weight loss.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Medicare’s new pay boost for primary care is angering specialists

WSS

Britney Spears to release memoir, 'The Woman In Me,' later this year

Women's World Cup brings attention to abuse in soccer

UnitedHealth sued over use of algorithm in Medicare Advantage plans

The debate over Covid

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Type 2 diabetes prevention programs work at large scale: study

entertainment

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

explore

Heart attack and stroke risk calculators need revising

Sickle cell gene therapy cures need to be accessible in Africa

Wildfire smoke exposes gaps in outdoor worker protections

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

BioMarin wins approval for gene therapy to treat hemophilia A

EU fines Illumina $475 million over Grail acquisition

Sports medicine is finally prioritizing gender equality

First transplant of an entire human eye performed

ChatGPT in medicine: STAT answers readers' burning questions

Weight loss drugs should be covered by insurers, AMA says

explore

Rapinoe says her retirement call will help US women's soccer team to focus at World Cup

Experimental asthma app from Apple and Anthem shows promise

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

Tornado touches down near Chicago's O'Hare airport amid extreme weather nationwide

NIH chief: government has fallen behind pharma on clinical trials

White House drug czar issues call for 'recovery

focus

explore

leisure time

explore